Bottom line
What does BIPIX hold?
BIPIX held 159 positions as of Jul 31, 2026. Its largest holding is N/a at 6.70% of the fund, and the top 10 positions add up to 30.5%. By asset type it is 78% stocks, 24% repurchase agreements, 2% cash & short-term funds.
Updated Sep 23, 2026
BIPIX top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | N/a SOCIETE' GENERALE 3.53 , 8/03/2026 |
Repurchase agreements | 6.70% | $7.9M |
| 2 | N/a CF Secured 3.53 , 8/03/2026 |
Repurchase agreements | 5.15% | $6.1M |
| 3 | N/a HSBC SECURITIES (USA), INC. 3.52 , 8/03/2026 |
Repurchase agreements | 4.12% | $4.9M |
| 4 | N/a NATWEST MARKETS PLC 3.51 , 8/03/2026 |
Repurchase agreements | 4.12% | $4.9M |
| 5 | N/a UMB FINANCIAL CORP. 3.39 , 8/03/2026 |
Repurchase agreements | 3.16% | $3.7M |
| 6 | Agpxx Invesco Government & Agency Portfolio |
Cash & short-term funds | 2.40% | $2.9M |
| 7 | Apogee Therapeutics Inc Apogee Therapeutics, Inc. |
Stocks | 1.29% | $1.5M |
| 8 | N/a ROYAL BANK OF CANADA 3.44 , 8/03/2026 |
Repurchase agreements | 1.24% | $1.5M |
| 9 | Oruka Therapeutics Inc Oruka Therapeutics, Inc. |
Stocks | 1.20% | $1.4M |
| 10 | Dianthus Therapeutics Inc Dianthus Therapeutics, Inc. |
Stocks | 1.12% | $1.3M |
| 11 | Erasca Inc Erasca, Inc. |
Stocks | 1.08% | $1.3M |
| 12 | Twist Bioscience Corp Twist Bioscience Corporation |
Stocks | 1.08% | $1.3M |
| 13 | Kymera Therapeutics Inc Kymera Therapeutics, Inc. |
Stocks | 1.05% | $1.3M |
| 14 | Spyre Therapeutics Inc Spyre Therapeutics, Inc. |
Stocks | 1.04% | $1.2M |
| 15 | Revolution Medicines Inc Revolution Medicines, Inc. |
Stocks | 1.04% | $1.2M |
| 16 | Cg Oncology Inc CG oncology, Inc. |
Stocks | 1.03% | $1.2M |
| 17 | Protagonist Therapeutics Inc Protagonist Therapeutics, Inc. |
Stocks | 1.03% | $1.2M |
| 18 | Praxis Precision Medicines Inc Praxis Precision Medicines, Inc. |
Stocks | 1.02% | $1.2M |
| 19 | Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals, Inc. |
Stocks | 1.01% | $1.2M |
| 20 | Cogent Biosciences Inc Cogent Biosciences, Inc. |
Stocks | 0.99% | $1.2M |
| 21 | Natera Inc Natera, Inc. |
Stocks | 0.99% | $1.2M |
| 22 | Arrowhead Pharmaceuticals Inc Arrowhead Pharmaceuticals, Inc. |
Stocks | 0.95% | $1.1M |
| 23 | Travere Therapeutics Inc Travere Therapeutics, Inc. |
Stocks | 0.95% | $1.1M |
| 24 | Roivant Sciences Ltd Roivant Sciences Ltd. |
Stocks | 0.95% | $1.1M |
| 25 | Relay Therapeutics Inc Relay Therapeutics, Inc. |
Stocks | 0.95% | $1.1M |
Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 23, 2026